Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Gains from Investment Securities (2016 - 2025)

Haemonetics has reported Gains from Investment Securities over the past 17 years, most recently at -$25.4 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 20574.8% year-over-year to -$25.4 million; the TTM value through Dec 2025 reached $6.0 million, down 61.76%, while the annual FY2025 figure was $15.7 million, 0.95% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$25.4 million at Haemonetics, down from $21.2 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $33.2 million in Q2 2023 and troughed at -$25.4 million in Q4 2025.
  • A 5-year average of $4.2 million and a median of $4.3 million in 2023 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 17468.78% in 2023 and later tumbled 20574.8% in 2025.
  • Year by year, Gains from Investment Securities stood at -$429000.0 in 2021, then tumbled by 3022.38% to -$13.4 million in 2022, then soared by 132.0% to $4.3 million in 2023, then tumbled by 102.87% to -$123000.0 in 2024, then tumbled by 20574.8% to -$25.4 million in 2025.
  • Business Quant data shows Gains from Investment Securities for HAE at -$25.4 million in Q4 2025, $21.2 million in Q3 2025, and $4.8 million in Q2 2025.